Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2005
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005087249A1 Protease inhibitor and preventives or remedies for diseases
09/22/2005WO2003099270A8 Methods of treating allergic reactions
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209452 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
09/22/2005US20050209341 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders
09/22/2005US20050209339 treating chronic rhinosinusitis such as allergic fungal sinusitis comprising daily oral administration of a composition from more than 500 mg to about 800 mg, preferably about 625 mg or 725 mg terbinafine base equivalent as hydrochloride
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209329 Potentiation of therapeutic effects of fatty acids
09/22/2005US20050209325 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209272 Novel quinuclidine derivatives and medicinal compositions containing the same
09/22/2005US20050209267 Thioether substituted imidazoquinolines
09/22/2005US20050209261 Rho-kinase inhibitors
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209230 2,4-Pyrimidinediamine compounds and their uses
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/22/2005US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050209185 Synergistic mixture; administering by inhalation; tiotropium bromide; metered dose inhaler, a dry powder inhaler; asthma, chronic obstructive pulmonary disease
09/22/2005US20050209169 Respiratory disorders such as pulmonary emphysema, acute respiratory distress syndrome, shock lung, cystic fibrosis (mucoviscidosis), chronic bronchitis, glomerulonephritis and rheumatoid arthritis
09/22/2005US20050209152 Polypeptoid pulmonary surfactants
09/22/2005US20050208583 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208496 Using enhanced interleukin gene expression as diagnostic indicator of respiratory system disorders
09/22/2005US20050208494 Novel proteins and dnas thereof
09/22/2005US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture
09/22/2005US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin
09/22/2005US20050207991 Aerosols for administering drugs by breathing and filling canisters with compounds like fluticasone propionate
09/22/2005US20050207989 High storage stability inhalable compositions
09/22/2005US20050207987 Mixture of tobramycin in carrier; aerosols; respiratory system disorders; drug delivery
09/22/2005US20050207984 Physical and chemical stability; homogeneity; particle size range; asthma, chronic obstructive pulmonary disease; 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane used as propellants
09/22/2005DE10253426B4 Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation
09/22/2005CA2787978A1 Interferon-beta for anti-virus therapy for respiratory diseases
09/22/2005CA2560098A1 2-aminoquinazoline derivative
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577387A1 Preventives/remedies for cancer
09/21/2005EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1577292A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/21/2005EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575506A2 Methods for improvement of lung function using tgf-beta inhibitors
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671731A Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671724A Prodrug, medicinal utilization thereof and process for producing the same
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671713A Novel derivative of flavone c-glycoside and composition containing the same
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671695A Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671662A Piperidine derivative, process for producing the same, and use
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671643A Bipolar trans carotenoid salts and their uses
09/21/2005CN1671435A Medicament dispenser
09/21/2005CN1671404A Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671359A Chinese herb medicine composition in the form of jelly
09/21/2005CN1669581A Medicinal composition containing dendritic cell-specific intercellular adhesion factor-3 snatch nonconformity element, cleaning supplies and uses thereof
09/21/2005CN1669559A Medicine for treating rhinitis
09/21/2005CN1669557A Bacill calmette-guerin polysaccharide nucleic acid spraying agent and preparation method thereof
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219777C Thiophene vitamine A
09/21/2005CN1219763C Substituted indole mannich bases
09/21/2005CN1219544C Capsule for fortifying kidney and nourishing qi and its preparation method
09/21/2005CN1219533C Medicine for treating chronic layngopharyngitis and preparation process thereof
09/21/2005CN1219513C Application of amyl ethyl quin ether hydrochloride
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/21/2005CN1219508C Mucilage antiseptic medicine composition capable of being locally administrated and sustainably released and its preparing method
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946486 Quaternary ammonium compounds
09/20/2005US6946478 Compounds
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
1 ... 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 ... 878